Page last updated: 2024-11-01

ns 1619 and Migraine Disorders

ns 1619 has been researched along with Migraine Disorders in 1 studies

NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Migraine is a common, disabling, neurological problem whose acute management would benefit from the development of purely neurally acting therapies."1.35Large conductance calcium-activated potassium channels (BKCa) modulate trigeminovascular nociceptive transmission. ( Goadsby, PJ; Immke, DC; Storer, RJ, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Storer, RJ1
Immke, DC1
Goadsby, PJ1

Other Studies

1 other study available for ns 1619 and Migraine Disorders

ArticleYear
Large conductance calcium-activated potassium channels (BKCa) modulate trigeminovascular nociceptive transmission.
    Cephalalgia : an international journal of headache, 2009, Volume: 29, Issue:12

    Topics: Action Potentials; Animals; Benzimidazoles; Cats; Cerebral Arteries; Electric Stimulation; Evoked Po

2009